Even though an overall significant difference was seen, indicating that there was an increasing trend (in the order of normal control, moderate, severe and critical) of this cytokine, no significance was reached between control and disease, or between critical and non-critical groups ( Fig. 2B ).
← all excerpts
Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19.
1
—
—